Results 141 to 150 of about 59,323 (260)

Characteristics of Patients With Advanced or Metastatic Urothelial Cancer Unable to Complete Six Cycles Chemotherapy

Cancer Medicine, Volume 15, Issue 6, June 2026.
ABSTRACT Background The optimal number of chemotherapy cycles prior to maintenance avelumab in frontline metastatic urothelial cancer (mUC) remains unknown. We hypothesize that baseline characteristics can identify which patients will complete six cycles of chemotherapy without radiographic disease progression, versus those who may benefit from ...
Francesca Jackson‐Spence, Domiziana Aspden, Vishwani Chauhan, Sofia Diaz, Catherine Graham, Matthew Young, Elizabeth Nally, John Connor Wells, Sara Coca Membribes, Charlotte Ackerman, Bernadett Szabados, Thomas Powles   +11 more
wiley   +1 more source

Trabeculectomy with mitomycin C for refractory glaucoma in blacks

, 1993
The use of one intraoperative application of mitomycin C at the filtration site has been effective in eyes at increased risk for failure of routine trabeculectomy.
Mermoud, A., Murray, A. D., Salmon, J. F.   +2 more
core  

The hsa_circ_0070354/miR‐4322/RAB3B Axis Facilitates the Carcinogenesis and Development of Non‐Small Cell Lung Cancer (NSCLC)

Cancer Medicine, Volume 15, Issue 6, June 2026.
ABSTRACT Background Circular RNA (hsa_circ_0070354), also known as circPTPN13, was demonstrated in our previous study that it can be used as a biomarker for diagnosing non‐small cell lung cancer (NSCLC). However, the mechanism of its role in the occurrence and development of NSCLC has not been investigated.
Yuejiao Huang, Shiyi Qin, Yu Zhang, Xinliang Gu, Ming Zheng, Guojie Ling, Lei Yang, Shaoqing Ju   +7 more
wiley   +1 more source

Development of an Artificial Intelligence Web Application for Predicting Chemotherapy‐Induced Neutropenia in Patients With Non‐Small Cell Lung Cancer: A Prospective Study

Cancer Medicine, Volume 15, Issue 6, June 2026.
ABSTRACT Objective This study aimed to develop an artificial intelligence (AI) web application for predicting chemotherapy‐induced neutropenia (CIN) in patients with non‐small cell lung cancer (NSCLC). Methods We conducted a prospective study including 310 patients who underwent 1047 chemotherapy cycles with NSCLC patients between 2019 and 2024 from ...
Jingyue Zhang, Yang Zhai, Chang Liu, Miaomiao Luo, Jiahui Liu, Qi Liu, Hanxu Zhang, Shijiao Cai, Ye Tian, Liangfu Lu, Linlin Zhang, Hengjie Yuan   +11 more
wiley   +1 more source

Recurrent pterygium treatment using mitomycin C, double amniotic membrane transplantation, and a large conjunctival flap

, 2018
Yu Monden, Fumi Hotokezaka, Ryoji Yamakawa Department of Ophthalmology, Kurume University School of Medicine, Fukuoka, Japan Purpose: The aim of this study was to evaluate the clinical outcomes of surgery for recurrent pterygia using mitomycin C (MMC ...
Hotokezaka F, Monden Y, Yamakawa R
core  

Efficacy of Disitamab Vedotin in Treating HER2 2+/FISH‐Bladder Cancer: A Case Report

Clinical Case Reports, Volume 14, Issue 6, June 2026.
Timeline of treatment and sustained partial response in a patient with HER2 2+/FISH‐ bladder cancer (October 2019 – June 2024). ABSTRACT Disitamab Vedotin achieved durable partial response (> 8 months PFS) in advanced HER2 2+/FISH‐ bladder cancer after first‐line chemo‐immunotherapy progression.
Zhi‐ruo Jin, Cheng‐yong Dong, Yu‐jun Li, Yang Zou, Xi‐mei Wang, Hui‐ying Li, Gang Wang, Xiao‐nan Cui, Ying Liu   +8 more
wiley   +1 more source

Unveiling Candidate Markers for Drug Resistance or Synthetic Lethality in Cervical Cancer: Integrative Analysis of Genetic and Pharmacoprofiling

Cancer Reports, Volume 9, Issue 6, June 2026.
ABSTRACT Introduction Systemic cervical cancer management continues to be challenging. Numerous chemotherapies have been approved, but predicting response is difficult due to the lack of biomarkers. Here, we analyze the genetic and protein profiles of 20 cervical cancer cell lines (CCCLs) and explore their correlation with drug response patterns to ...
Suzy Scholl, Elaine Del Nery, Pierre Gestraud, Maral Halladjian, Elodie Girard, Adèle Soria, Elodie Anthony, Leanne De Koning, Nicolas Servant, Els Berns, Maud Kamal   +10 more
wiley   +1 more source

Osteogenic Potential of a Three‐Phase Strontium‐ and Silicon‐Doped Tricalcium Silicate Cement on Dental Pulp Stem Cells: An In Vitro Study

Clinical and Experimental Dental Research, Volume 12, Issue 3, June 2026.
ABSTRACT Objective This study aimed to evaluate the osteogenic potential of a novel three‐phase cement composed of strontium‐doped hydroxyapatite (Sr‐HA), silicon‐doped hydroxyapatite (Si‐HA), and tricalcium silicate (C3S) on dental pulp stem cells (DPSCs) in vitro.
Nahid Nasrabadi, Ehsan Saburi, Hossein Bagheri, Atekeh Hosseinpour, Mahsa Ghorbani, Pooya Saeedi   +5 more
wiley   +1 more source

Results of Intraoperative Mitomycin C Application in Dacryocystorhinostomy

, 2009
Aims-To evaluate the long term results of intraoperative mitomycin C application in dacryocystorhinostomy (DCR) surgery compared with results of the conventional procedure.
CHEN, MUH-SHY;LIAO, SHU-LANG, 陳慕師;廖述朗   +1 more
core  

Mutation type‐specific transcriptomic signatures and readthrough therapy rescue in SMC1A‐related developmental and epileptic encephalopathy

Epilepsia, Volume 67, Issue 6, Page 3185-3198, June 2026.
Abstract Objective This study was undertaken to investigate the molecular consequences of pathogenic variants in the SMC1A gene—particularly those associated with developmental and epileptic encephalopathy (DEE85)—and to evaluate the therapeutic potential of ataluren in restoring SMC1A function and mitigating disease‐related transcriptomic and genomic ...
Maddalena Di Nardo, Francesca Sardina, Maria M. Pallotta, Iñigo Marcos‐Alcalde, Paulino Gómez‐Puertas, Cinzia Rinaldo, Ian D. Krantz, Antonio Musio   +7 more
wiley   +1 more source